Northern Beaches Clinical Research

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Obesity5 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Cytomegalovirus infection1 trial
• Familial hypercholesterolaemia1 trial
• Heart failure1 trial
• Peripheral artery disease1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 34 trials
• Phase 22 trials
• Phase 11 trial

Status

• Completed4 trials
• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Novo Nordisk A/S2 trials
• Axxium Life, Inc.1 trial
• ModernaTX, Inc.1 trial

Running trials

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

  NCT05567796· Phase 3· Novo Nordisk A/S· Source

Closed trials

• Completed

  A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

  NCT06326060· Phase 2· Novo Nordisk A/S· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

  NCT05882045· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered IM in Adult Participants

  NCT05762276· Phase 1· Axxium Life, Inc.· Source

• Completed

  Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

  NCT05616013· Phase 2· Eli Lilly and Company· Source

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· Phase 3· ModernaTX, Inc.· Source